1. ScholarBank@NUS

Kam Man Hui

rp08035

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Kam Man Hui
Variants
HUI, KAM MAN
Hui, K.M.
HUI, KAM M.
Hui, K.
 
Main Affiliation
 
Faculty
 
Email
gmshkm@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2023]
Type:  Article
File Format:  Adobe PDF
Date Issued:  [2010 TO 2019]

Results 1-11 of 11 (Search time: 0.02 seconds).

Issue DateTitleAuthor(s)
12017A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinomaDai X.; Wang L. ; Deivasigamni A.; Looi C.Y.; Karthikeyan C.; Trivedi P.; Chinnathambi A.; Alharbi S.A.; Arfuso F.; Dharmarajan A.; Goh B.C. ; Hui K.M. ; Kumar A.P. ; Mustafa M.R.; Sethi G. 
22017An anti-human lutheran glycoprotein phage antibody inhibits cell migration on laminin-511: Epitope mapping of the antibodyEnomoto-Okawa Y.; Maeda Y.; Harashima N.; Sugawara Y.; Katagiri F.; Hozumi K.; Hui K.M. ; Nomizu M.; Ito Y.; Kikkawa Y.
32017An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemiaHer Z.; Yong K.S.M.; Paramasivam K.; Tan W.W.S.; Chan X.Y.; Tan S.Y.; Liu M. ; Fan Y.; Linn Y.C. ; Hui K.M. ; Surana U. ; Chen Q. 
42017Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancerXia H.; Hui K.M. 
52015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
62017Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiformeNewman J.P.; Wang G.Y.; Arima K.; Guan S.P. ; Waters M.R.; Cavenee W.K.; Pan E.; Aliwarga E. ; Chong S.T.; Kok C.Y.L.; Endaya B.B.; Habib A.A.; Horibe T.; Ng W.H. ; Ho I.A.W. ; Hui K.M. ; Kordula T.; Lam P.Y.P. 
74-Sep-2012MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular CarcinomaXia, H.; Ooi, L.L.P.J.; Hui, K.M. 
82019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
92019Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient PopulationsTeo, W.-Y.; Sekar, K.; Seshachalam, P.; Shen, J.; Chow, W.-Y.; Lau, C.C.; Yang, H.K.; Park, J.; Kang, S.-G.; Li, X.; Nam, D.-H.; Hui, K.M. 
102015The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinomaXia H.; Chen J.; Shi M.; Deivasigamani A.; Ooi L.L.P.J. ; Hui K.M. 
112014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G.